TRHC Fills the Information Gap on COVID-19 Proposed Therapies with a New Digital Resource

Moorestown, NJ, May 19, 2020 – Tabula Rasa HealthCare® Corporation (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today published on the web the TRHC COVID-19 Treatment and Therapy Digital Resource. Developed by TRHC’s Precision Pharmacotherapy Research & Development Institute, the resource provides a comprehensive analysis and clinical reviews of potential treatments and therapies for COVID-19.

“There are knowledge gaps surrounding the proposed treatments for COVID-19,” said TRHC Chairman and CEO Calvin H. Knowlton, PhD. “To address this need, our Precision Pharmacotherapy Research & Development Institute completed a systematic review of literature on the latest COVID-19 treatments and therapies and compiled them into a single source, eliminating the need for providers to access multiple sources to understand treatment options.”

Currently, there are more than 20 therapies and treatments being studied across the globe. Many are being fast-tracked for immediate use, due to the unique conditions of the novel coronavirus and COVID-19.

“Designed for clinical use, our COVID-19 Treatment and Therapy Digital Resource provides an in-depth review of each medication’s mode of action, dosing guidelines, clinical trial information, adverse drug events, metabolism and elimination, as well as the proposed level of evidence based on the mechanism of action,” states TRHC Chief Scientific Officer Jacques Turgeon, BPharm, PhD.

TRHC Precision Pharmacotherapy Research & Development Institute Chief Operating Officer Veronique Michaud, BPharm, PhD adds, “We are constantly updating this resource with evidence from the latest clinical trials and journal articles. We feel this resource is what the clinical community needs to help sort through the vast number of treatments to determine the best course of action for the patients they treat.”

About Tabula Rasa HealthCare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology, and solutions that enable healthcare organizations to optimize performance to improve patient outcomes, reduce hospitalizations, lower healthcare costs, and manage risk. Medication risk management is TRHC’s lead offering, and its cloud-based software applications provide solutions for a range of payers, providers, and other healthcare organizations. For more information, visit